Deputy Director Johns Hopkins Greenberg Bladder Cancer Institute, Professor of Oncology and Urology Johns Hopkins University Baltimore, Maryland
Dr. Hahn is a professor of oncology and urology at the Johns Hopkins University School of Medicine. He serves as the director of the medical oncology bladder cancer program and the deputy director of the Johns Hopkins Greenberg Bladder Cancer Institute. Dr. Hahn is an internationally recognized authority in the conduct of bladder cancer novel therapeutic clinical trials and translational investigations. He maintains an active clinical practice and sees patients with urothelial cancers of all locations and stages including non-muscle invasive bladder cancer. Dr. Hahn’s clinical and translational research interests focus on improving outcomes for patients with urothelial cancers through: 1) The development of novel epigenetic, targeted, and immunomodulatory approaches to treat and prevent urothelial cancer; 2) The credentialing of the naturally-occurring, immunocompetent canine-human tumor model as a relevant comparative oncology model optimal for the pre-clinical study of candidate human urothelial cancer biomarkers and therapeutics; and 3) The identification and validation of predictive biomarkers relevant to urothelial cancers. In addition to his efforts at Johns Hopkins, Dr. Hahn serves as the bladder cancer chairman of the Eastern Cooperative Oncology Group - American College of Radiology Imaging Network (ECOG-ACRIN), participates on the NCI Bladder Cancer Task Force, and serves on the scientific advisory board of the Bladder Cancer Advocacy Network.
Disclosure information not submitted.
Friday, April 28, 2023
2:30 PM – 2:55 PM CST
Saturday, April 29, 2023
6:00 PM – 8:00 PM CST